ArticleAnnals of hematology2025

Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS).

K Nachtkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.